WorldCare Clinical, in Conjunction With the Massachusetts General Hospital (MGH) Department of Radiology, Announces the Imaging Biomarkers in Clinical Trials Conference
WorldCare Clinical, LLC (WCC), a leading imaging CRO focused on
maximizing the precision and accuracy of independent assessments in
clinical trials, today announced it is hosting a complimentary
conference on Imaging in Clinical Trials - Removing Bias and
Increasing Precision and Accuracy, which will be held on Friday, April
27, from 8:30 to 11:30 a.m. at the Holiday Inn Boston at Beacon Hill.
This complimentary conference is being held in conjunction with the
Imaging Biomarkers in Clinical Trials conference sponsored by the
Massachusetts General Hospital (MGH) Department of Radiology on April
WCC's complimentary session will feature its own in-house experts, who
will discuss the operational considerations for conducting imaging
clinical trials and the value of a blinded independent central review
(BICR), including when and why to include one in a study design.
Additionally, they'll examine the importance of reader training,
testing and variability monitoring, as well as innovative digital
solutions for optimizing workflow and site management.
Imaging Biomarkers in Clinical Trials: Current Practice & Future
Trends, which will be held in the O'Keefe Auditorium at MGH in Boston,
is a two-day conference featuring keynote speaker Dwaine Rieves, MD,
director of the FDA's Division of Medical Imaging Products, and
experts from MGH. Speakers will review the current practice of imaging
biomarkers in clinical trials in oncology, cardiovascular, metabolic,
bone and joint diseases and highlight advanced imaging techniques that
have potential as surrogate biomarkers.
Imaging biomarkers serve as important endpoints for clinical trials in
the approval process for therapeutic drugs. Various criteria have been
developed for objective interpretation of imaging studies.
Additionally, there are emerging imaging techniques that have the
potential for applications as surrogate endpoints for clinical trials.
This conference will provide valuable insight for medical directors,
physicians, and PhD scientists at academic medical centers,
pharmaceutical companies, contract research organizations, and
biotechnology companies that design and manage clinical trials, as
well as radiologists who interpret images and non-radiologists
involved in imaging clinical trials. Attendees will hear from experts
on the latest imaging criteria, including RECIST and WHO, novel
imaging biomarkers and emerging modalities like PET/MR, elastography,
DCE, and perfusion being used in drug development.
The educational format of the conference will give attendees an
opportunity to hear from leading experts and participate in Q&A
sessions on topics relating to imaging biomarkers and advanced imaging
techniques. Additionally, case studies of previous clinical trials and
their successes and failures will be referenced.
For more information or to register for WCC's free conference, visit:
To view the conference agenda or to register for the MGH conference,
About WorldCare ClinicalWorldCare Clinical (WCC) is a leading imaging
CRO that employs imaging expertise, innovative technology and
operational excellence to maximize the precision and accuracy of a
blinded independent central review of clinical trial data. Originally
founded in 1992 by the Massachusetts General Hospital (MGH) Department
of Radiology, WCC has evolved as an independent company while
maintaining a strategic relationship with MGH. With a 20-year focus on
imaging trials and their specific requirements, WCC provides sponsors
with extensive medical, operational, and image management expertise in
support of even the most complex study designs. For more information,